TABLE 3

Effect of β2-adrenoceptor agonist/glucocorticoid combinations on GRE-dependent transcription

As described in Fig. 2, GRE BEAS-2B cells were treated with various concentrations of fluticasone (30 pM to 300 nM), budesonide (30 nM to 300 nM) and dexamethasone (30 nM to 1 μM) in the absence and presence of fixed concentrations of salmeterol (100 nM), salbutamol (1 μM), and formoterol (10 nM). After 6 h, cells were harvested for luciferase activity determination. pEC50 values were calculated for each glucocorticoid in the presence or absence of each β2-adrenoceptor agonist. Overall activation of the GRE reporter and the enhancement evoked by each β2-adrenoceptor over that produced by the glucocorticoid alone are shown. See Fig. 2 and text for further details.


Treatments

N

pEC50 ± S.E.

GRE Activation

Enhancement
Glucocorticoid
β2-AdrenoceptorAgonist
M -fold -fold
Fluticasone 18 −8.69 ± 0.08 13.8
+Salmeterol 6 −8.74 ± 0.19 31.8** 2.30
+ Formoterol 6 −8.70 ± 0.19 29.9* 2.16
+Salbutamol 6 −8.65 ± 0.17 37.1** 2.68
Budesonide 17 −8.65 ± 0.05 15.4
+Salmeterol 6 −8.56 ± 0.09 30.0* 1.94
+ Formoterol 6 −8.57 ± 0.05 34.7* 2.25
+Salbutamol 5 −8.54 ± 0.05 28.3*** 1.84
Dexamethasone 16 −7.73 ± 0.07 14.5
+Salmeterol 6 −7.75 ± 0.11 34.4** 2.38
+ Formoterol 4 −7.57 ± 0.10 37.7* 2.61

+Salbutamol
6
−7.60 ± 0.15
32.9*
2.27